Breaking News Instant updates and real-time market news.

TSLA

Tesla

$334.80

-12.8 (-3.68%)

12:04
08/15/18
08/15
12:04
08/15/18
12:04

Silver Lake would like to participate in Tesla deal, DealBook says

Silver Lake, which previously teamed up with Michael Dell to help take Dell Inc. private, is now working with Tesla founder and CEO Elon Musk, The New York Times previously reported, citing people with direct knowledge of the matter. Silver Lake is not being paid for its role, but instead hopes to participate in whatever deal comes together, The Times' DealBook said in a report published earlier this morning. Reference Link

  • 29

    Oct

TSLA Tesla
$334.80

-12.8 (-3.68%)

08/10/18
MSCO
08/10/18
NO CHANGE
Target $291
MSCO
Equal Weight
Morgan Stanley says Tesla LBO doesn't seem feasible, equity buyout might be
Morgan Stanley analyst Adam Jonas said a leveraged buyout, or LBO, of Tesla does not appear to be feasible, even with less than $10B of incremental debt. However, he believes Tesla could consider an auction for its shares in the private equity market, financed by existing shareholders, new strategic investors, the possible divestiture of assets such as Tesla's autonomous and shared mobility assets and "possibly some help from SpaceX." However, Jonas notes that he has no knowledge of an equity buyout, or EBO, being considered by the company. He maintains an Equal Weight rating and $291 price target on Tesla shares.
08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.
08/08/18
RBCM
08/08/18
NO CHANGE
Target $110
RBCM
Outperform
RBC Capital revisits idea of Celgene going private after Tesla proposal
Following yesterday's news that Tesla (TSLA) CEO Elon Musk would like to see his company go private, RBC analyst Brian Abrahams revisited his prior analysis of whether Celgene (CELG) should go private in order to better capture the medium-term value of future Revlimid cash flows not being appreciated by public markets and avoid volatility as it transitions to a post-Revlimid business model. Though acknowledging that the two companies are in completely different industries, he thinks the example of Musk shows that performing such a transaction on a large company "may not be completely unrealistic," Abrahams said. Such an LBO, or perhaps more likely an acquisition by a larger pharmaceutical company, could possibly help capture more value from Celgene's commercial and pipeline products, concludes Abrahams, who has an Outperform rating and $110 price target on Celgene shares.
08/08/18
BARD
08/08/18
NO CHANGE
Target $411
BARD
Outperform
Tesla $420 buyout price mentioned by Musk too low, says Baird
Baird analyst Ben Kallo believes the Tesla buyout price of $420 mentioned by Elon Musk is too low. He expects the shares to trade above that mark as investors will demand a higher premium, which will coincide with short covering. Kallo reiterated his Outperform rating and $411 price target on Tesla shares.

TODAY'S FREE FLY STORIES

ATRA

Atara Biotherapeutics

$35.47

-1.72 (-4.62%)

05:05
01/23/19
01/23
05:05
01/23/19
05:05
Initiation
Atara Biotherapeutics initiated  »

Mizuho starts Atara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGCO

Agco

$62.76

-1.93 (-2.98%)

04:59
01/23/19
01/23
04:59
01/23/19
04:59
Downgrade
Agco rating change  »

Agco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 06

    Feb

  • 07

    Feb

LOGI

Logitech

$33.69

0.24 (0.72%)

04:57
01/23/19
01/23
04:57
01/23/19
04:57
Upgrade
Logitech rating change  »

Logitech upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNP

TEN, Ltd.

$3.30

-0.09 (-2.65%)

04:56
01/23/19
01/23
04:56
01/23/19
04:56
Downgrade
TEN, Ltd. rating change  »

TEN, Ltd. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Stephens building materials analyst to hold group dinner »

Building Materials…

HSKA

Heska

$97.20

0.46 (0.48%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Heska management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
UBS software analyst to hold an analyst/industry conference call »

Software Analyst Jennifer…

ENLK

EnLink Midstream Partners

$13.30

-0.28 (-2.06%)

, ENLC

EnLink Midstream

$11.51

-0.24 (-2.04%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
EnLink Midstream Companies to hold a special shareholder meeting »

Special Shareholder…

ENLK

EnLink Midstream Partners

$13.30

-0.28 (-2.06%)

ENLC

EnLink Midstream

$11.51

-0.24 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

04:55
01/23/19
01/23
04:55
01/23/19
04:55
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

January Richmond Fed…

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Stephens electrical equipment analyst to hold a luncheon »

Electrical Equipment…

SSTI

ShotSpotter

$41.73

-0.49 (-1.16%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
ShotSpotter management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ALTR

Altair

$31.50

0.59 (1.91%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Altair management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

OBSV

ObsEva

$13.26

-0.46 (-3.35%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
ObsEva management to meet with Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

TUSK

Mammoth Energy

$21.82

-0.93 (-4.09%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Mammoth Energy management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 10

    Feb

ECL

Ecolab

$152.77

-1.78 (-1.15%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Ecolab management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 07

    Feb

  • 19

    Feb

  • 28

    May

NBRV

Nabriva Therapeutics

$1.90

-0.07 (-3.55%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Nabriva Therapeutics to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 30

    Apr

HDS

HD Supply

$40.13

0.11 (0.27%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
HD Supply management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ONCS

OncoSec

$0.70

-0.0135 (-1.90%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
OncoSec management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

SAIC

SAIC

$65.47

-0.56 (-0.85%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
SAIC management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
World Economic Forum to hold a meeting »

World Economic Forum…

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Jefferies macro analyst to hold an analyst/industry conference call »

Analyst Zervos discusses…

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Stephens restaurants analyst to hold a luncheon »

Restaurants Analyst…

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
UBS consumer analyst to hold luncheon »

Consumer & Strategy…

IDCC

InterDigital

$71.41

-0.91 (-1.26%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
InterDigital management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

INSE

Inspired Entertainment

$5.91

0.27 (4.79%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Inspired Entertainment management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.